Diabetic kidney disease is a common complication of diabetes and it is estimated that by 2040 it may affect 200 million people. New stem cell research Cyndacel-M was in a pathway to lead a huge breakthrough in the treatment of chronic kidney disease caused by diabetes. The study would be led under the guidance of Professor Timothy O’Brien, Director of the Regenerative Medicine Institute at the National University of Ireland. Chronic kidney disease is marked by the gradual destruction of kidney tissue over time and is a major cause of sickness and death in the Europe. This new €6 million research project will evaluate the clinical safety and efficacy of the next-generation cell therapy discovered by Galway-based Orbsen Therapeutics.
Hope the Project would succeed in all terms helping in new revolution of kidney disease cure.